Pulmatrix Price Performance
Pulmatrix stock opened at $3.61 on Monday. Pulmatrix has a 52 week low of $3.16 and a 52 week high of $15.60. The stock has a fifty day moving average of $3.63 and a 200-day moving average of $4.34.
Hedge Funds Weigh In On Pulmatrix
An institutional investor recently raised its position in Pulmatrix stock. Renaissance Technologies LLC lifted its holdings in shares of Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) by 7.3% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 121,920 shares of the biotechnology company’s stock after buying an additional 8,300 shares during the period. Renaissance Technologies LLC owned about 3.60% of Pulmatrix worth $560,000 as of its most recent filing with the SEC. 44.12% of the stock is currently owned by institutional investors and hedge funds.
Pulmatrix, Inc, a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
- Get a free copy of the StockNews.com research report on Pulmatrix (PULM)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.